NCT05636397View on ClinicalTrials.gov

Safety and PK-PD Study of Oral L-CIT in Preterm Infants with BPD±PH and NEC

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

March 31, 2028

Conditions
BPD - Bronchopulmonary DysplasiaPulmonary HypertensionNEC
Interventions
DIETARY_SUPPLEMENT

L-Citrulline

Citrulline is a nonessential amino acid made in the small intestine, occurs naturally in the body, and is believed to help reduce inflammation.L-CIT is a part of the urea cycle, produced as a by-product along with nitric oxide (NO).

Trial Locations (1)

M5G 1X8

RECRUITING

The Hospital For Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER